L. Rouquier

Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease

B. Scatton, France Javoy‐Agid, L. Rouquier et al. · Brain Research · 1983 · 723 citations

Cortical Dopamine, Psychiatry, Neurophysiology +14

Neurochemical Characteristics of Amisulpride, an Atypical Dopamine D2/D3 Receptor Antagonist with Both Presynaptic and Limbic Selectivity

H. Schoemaker, Y. Claustre, Dominique Fage et al. · Journal of Pharmacology and Experimental Therapeutics · 1997 · 372 citations · Full text

Dopamine deficiency in the cerebral cortex in Parkinson disease

B. Scatton, L. Rouquier, F. Javoy‐Agid et al. · Neurology · 1982 · 180 citations

Neuropsychology, Neurological Disorder, Psychopharmacology +16

SSR180711, a Novel Selective α7 Nicotinic Receptor Partial Agonist: (1) Binding and Functional Profile

Bruno Biton, Olivier Bergis, Frédéric Galli et al. · Neuropsychopharmacology · 2006 · 175 citations · Full text

Molecular Pharmacology, Functional Profile, Medicine +6

Effect of local injection of 8-OH-DPAT into the dorsal or median raphe nuclei on extracellular levels of serotonin in serotonergic projection areas in the rat brain

Gilles Bonvento, B. Scatton, Y. Claustre et al. · Neuroscience Letters · 1992 · 126 citations

Median Raphe Nuclei, Neurophysiology, Neuroanatomy +14